17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use

N. Farzan, S. J. Vijverberg, N. Hernandez-Pacheco, E. H. D. Bel, V. Berce, K. Bønnelykke, H. Bisgaard, E. G. Burchard, G. Canino, J. C. Celedón, F. T. Chew, W. C. Chiang, M. M. Cloutier, E. Forno, B. Francis, D. B. Hawcutt, E. Herrera-Luis, M. Kabesch, L. Karimi, E. MelénS. Mukhopadhyay, S. K. Merid, C. N. Palmer, M. Pino-Yanes, M. Pirmohamed, U. Potočnik, K. Repnik, M. Schieck, A. Sevelsted, Y. Y. Sio, R. L. Smyth, P. Soares, C. Söderhäll, K. G. Tantisira, R. Tavendale, S. M. Tse, S. Turner, K. M. Verhamme, A.-H. Maitland-van der Zee

Research output: Contribution to journalLetter

6 Citations (Scopus)
4 Downloads (Pure)
Original languageEnglish
Pages (from-to)2083-2088
Number of pages6
JournalAllergy
Volume73
Issue number10
Early online date9 Jul 2018
DOIs
Publication statusPublished - 29 Oct 2018

Cite this

Farzan, N., Vijverberg, S. J., Hernandez-Pacheco, N., Bel, E. H. D., Berce, V., Bønnelykke, K., ... Maitland-van der Zee, A-H. (2018). 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use. Allergy, 73(10), 2083-2088. https://doi.org/10.1111/all.13499